|
 |
|
EMPLOYMENT MARKET: College graduates attend a job fair in Hangzhou, east China's Zhejiang Province, on November 29, 2014. Figures from the National Bureau of Statistics show that a total of 13.22 million new jobs were created in China in 2014, beating the full-year target. Urban employment increased slightly from 13.1 million recorded in 2013. Some 773 million people had been employed nationwide with 393 million in urban areas by the end of 2014, the NBS data showed (ZHU YINWEI) |
H7N9 Symptoms
Chinese scientists have used a targeted antibody to significantly reduce H7N9 symptoms in monkeys.
The study, published in British medical journal Clinical Infectious Diseases, demonstrates patients infected with H7N9 virus often end up dead after severe pneumonia and systemic inflammation caused by acute lung infection (ALI).
Part of the high death rate from of H7N9 is due to very limited effective treatment options.
African green monkeys were inoculated with the H7N9 virus and treated intravenously with an antibody. The treatment markedly reduced ALI and systemic inflammation, according to the study.
The results have shown promising progress in helping treat the virus in humans.
The study was led by Sun Shihui from the Beijing Institute of Microbiology and Epidemiology and Zhao Guangyu from the Academy of Military Medical Science.
Since H7N9 avian flu killed three people in China in March 2013, the flu has repeatedly cropped up in winter and spring seasons.
Patent Applications
China accepted about 928,000 invention patent applications in 2014, some 103,000 more than in 2013, the State Intellectual Property Office (SIPO) said on January 15.
SIPO director Shen Changyu said invention patent applications accounted for 39.3 percent of all patent applications in 2014, compared with a 34.7 percent in 2013. Invention patent application growth slowed from 26.3 percent in 2013 to 12.5 percent in 2014.
China grants patents for three major categories: invention, utility model and design.
Database on Cancer
China has established its first database on prostate cancer, a disease of rising frequency amongst the nation's aging population.
Initiated by Wu Jieping Medical Foundation, the Chinese Prostate Cancer Database (C-CaP) opened on January 19 in Zhejiang Cancer Hospital in Hangzhou, east China's Zhejiang Province. The database will collect information on diagnosis and treatment to track its incidence and development.
The second most common cancer in men globally, prostate cancer is on the increase in China. Data from the Chinese Anti-Cancer Association show the cancer's incidence in China increased more than tenfold in the past two decades.
Health experts believe China's aging population and the use of more advanced detection methods have contributed to the increasing incidence. | 
